Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Enfrentando la enfermedad de Alzheimer en los países en desarrollo.
Rev Neuropsiquiatr 80 (2), 2017 (P. 105-110)
Recibido: 03/02/2017 Aceptado: 12/06/2017
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
more
Rev Panam Salud Publica 2023;47:e141. https://doi.org/10.26633/RPSP.2023.141
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
PQDx 0183‐060‐00 WHO
PQ Public Report
October/2016, version 5.0
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
Plataforma clínica mundial de la COVID-19. Formulario de notificación de casos presuntos de síndrome inflamatorio multisistémico (SIM) en niños y adolescentes que coincide cronológicamente con la COVID-19
PQDx 0053-006-00 WHO
PQ Public Report
June/2016, version 2.0
PQDx 0179-012-00 WHO
PQDx Public Report
June/2017, version 4.0
PQDx 0033-013-00 WHO
PQ Public Report
July/2016, version 5.0
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...and management of this infectious disease are critical. Given its mandate to improve human health and control disease among its Member States, WHO has led the production of this fifth edition of Laboratory techniques in rabies.
more
PQDx 0214-064-00
WHO PQDx PR
April/2016, version 3.0